BioMedNewsBreaks – DarioHealth (NASDAQ: DRIO) Announces Plans to Release Q2 Financials, Provide Company Update

August 7, 2020 09:45:08

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, will release its second-quarter earnings on June 30, 2020, as well as host a 9 a.m. ET conference call and webcast on the same day. Hosted by CEO Erez Raphael, president and North America general manager Rick Anderson, and CFO Zvi Ben-David, the call will include a business update as well as an earnings discussion. Interested parties are invited to participate by dialing 1-844-369-8770 (in the United States) or 1-862-298-0840 (internationally) or visiting Those who are participating are asked to dial in or log in 10 minutes prior to the start of the event. In addition, a recording of the earnings call will be posted approximately two hours after the conclusion of the call and will remain available through Aug. 26, 2020. To access that recording, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 36466. The webcast recording will be available through Nov. 12, 2020.

To view the full press release, visit

About DarioHealth Corp.

DarioHealth Corp. is a leading, global, digital-therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. DRIO’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario(TM) mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, visit

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork